Meanwhile, Shigeta K et al. also observed that the fibroblast growth factor receptor 3 (FGFR3) level was significantly lower in primary MIBC patients than it was in UTUC-BC patients (including NMIBC and MIBC, p < 0.01). Here, FGFR3 is linked to breast cancer.